Martin Newman is a senior executive and strategic problem-solver with a focus on knowledge-intensive products and services within the medical device sector. As Chief Operating Officer/Technical at Novagenesis, LLC since 2011, he applies his extensive experience to facilitate revenue generation and smart solutions, particularly for companies requiring remediation in Design Controls or FDA 483 letters.